{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:11:04Z","timestamp":1779333064215,"version":"3.51.4"},"reference-count":27,"publisher":"Japanese Circulation Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2020,5,25]]},"DOI":"10.1253\/circj.cj-19-0875","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T22:04:36Z","timestamp":1587765876000},"page":"1020-1027","source":"Crossref","is-referenced-by-count":13,"title":["Predictor and Mid-Term Outcome of Clinically Significant Thrombocytopenia After Transcatheter Aortic Valve Selection"],"prefix":"10.1253","volume":"84","author":[{"given":"Shinji","family":"Takahashi","sequence":"first","affiliation":[{"name":"Department of Cardiology, Teikyo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Teikyo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Teikyo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiga","family":"Katayama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Teikyo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Hioki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Teikyo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirosada","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Teikyo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Kawasugi","sequence":"additional","affiliation":[{"name":"Faculty of Medical Technology, Teikyo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Kozuma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Teikyo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Dvir D, Genereux P, Barbash IM, Kodali S, Ben-Dor I, Williams M, et al. Acquired thrombocytopenia after transcatheter aortic valve replacement: Clinical correlates and association with outcomes. <i>Eur Heart J<\/i> 2014; 35: 2663\u20132671.","DOI":"10.1093\/eurheartj\/ehu082"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. McCabe JM, Huang PH, Riedl LA, Devireddy SR, Grondell J, Connors AC, et al. Incidence and implications of idiopathic thrombocytopenia following transcatheter aortic valve replacement with the Edwards Sapien(\u00a9) valves: A single center experience. <i>Catheter Cardiovasc Interv<\/i> 2014; 83: 633\u2013641.","DOI":"10.1002\/ccd.25206"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Flaherty MP, Mohsen A, Moore JB 4th, Bartoli CR, Schneibel E, Rawasia W, et al. Predictors and clinical impact of pre-existing and acquired thrombocytopenia following transcatheter aortic valve replacement. <i>Catheter Cardiovasc Interv<\/i> 2015; 85: 118\u2013129.","DOI":"10.1002\/ccd.25668"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Jilaihawi H, Doctor N, Chakravarty T, Kashif M, Mirocha J, Cheng W, et al. Major thrombocytopenia after balloon-expandable transcatheter aortic valve replacement: Prognostic implications and comparison to surgical aortic valve replacement. <i>Catheter Cardiovasc Interv<\/i> 2015; 85: 130\u2013137.","DOI":"10.1002\/ccd.25430"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hernandez-Enriquez M, Chollet T, Bataille V, Campelo-Parada F, Boudou N, Bouisset F, et al. Comparison of the frequency of thrombocytopenia after transfemoral transcatheter aortic valve implantation between balloon-expandable and self-expanding valves. <i>Am J Cardiol<\/i> 2019; 123: 1120\u20131126.","DOI":"10.1016\/j.amjcard.2018.12.036"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hernandez-Enriquez M, Regueiro A, Romaguera R, Andrea R, Gomez-Hospital JA, Pujol-Lopez M, et al. Thrombocytopenia after transcatheter aortic valve implantation: A comparison between balloon-expandable and self-expanding valves. <i>Catheter Cardiovasc Interv<\/i> 2019; 93: 1344\u20131351.","DOI":"10.1002\/ccd.27907"},{"key":"7","unstructured":"7. Anand A, Harley C, Visvanathan A, Shah ASV, Cowell J, MacLullich A, et al. The relationship between preoperative frailty and outcomes following transcatheter aortic valve implantation: A systematic review and meta-analysis. <i>Eur Heart J Qual Care Clin Outcomes<\/i> 2017; 3: 123\u2013132."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Watanabe Y, Kozuma K, Hioki H, Kawashima H, Nara Y, Kataoka A, et al. Comparison of results of transcatheter aortic valve implantation in patients with versus without active cancer. <i>Am J Cardiol<\/i> 2016; 118: 572\u2013577.","DOI":"10.1016\/j.amjcard.2016.05.052"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Mitrosz M, Kazimierczyk R, Chlabicz M, Sobkowicz B, Waszkiewicz E, Lisowska A, et al. Perioperative thrombocytopenia predicts poor outcome in patients undergoing transcatheter aortic valve implantation. <i>Adv Med Sci<\/i> 2018; 63: 179\u2013184.","DOI":"10.1016\/j.advms.2017.11.001"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Biasco L, Ferrari E, Pedrazzini G, Faletra F, Moccetti T, Petracca F, et al. Access sites for TAVI: Patient selection criteria, technical aspects, and outcomes. <i>Front Cardiovasc Med<\/i> 2018; 5: 88.","DOI":"10.3389\/fcvm.2018.00088"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Asakura H, Takahashi H, Uchiyama T, Eguchi Y, Okamoto K, Kawasugi K, et al. Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. <i>Thromb J<\/i> 2016; 14: 42.","DOI":"10.1186\/s12959-016-0117-x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document. <i>J Am Coll Cardiol<\/i> 2012; 60: 1438\u20131454.","DOI":"10.1016\/j.jacc.2012.09.001"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Stasi R. How to approach thrombocytopenia. <i>Hematology Am Soc Hematol Educ Program<\/i> 2012; 2012: 191\u2013197.","DOI":"10.1182\/asheducation.V2012.1.191.3798260"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Wang TY, Ou FS, Roe MT, Harrington RA, Ohman EM, Gibler WB, et al. Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice. <i>Circulation<\/i> 2009; 119: 2454\u20132462.","DOI":"10.1161\/CIRCULATIONAHA.108.827162"},{"key":"15","unstructured":"15. Thachil J, Warkentin TE. How do we approach thrombocytopenia in critically ill patients? <i>Br J Haematol<\/i> 2017; 177: 27\u201338."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Mitrosz M, Chlabicz M, Hapaniuk K, Kaminski KA, Sobkowicz B, Piszcz J, et al. Thrombocytopenia associated with TAVI: The summary of possible causes. <i>Adv Med Sci<\/i> 2017; 62: 378\u2013382.","DOI":"10.1016\/j.advms.2017.04.003"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Mitrosz M, Kazimierczyk R, Sobkowicz B, Waszkiewicz E, Kralisz P, Frank M, et al. The causes of thrombocytopenia after transcatheter aortic valve implantation. <i>Thromb Res<\/i> 2017; 156: 39\u201344.","DOI":"10.1016\/j.thromres.2017.05.020"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. De Larochelliere H, Puri R, Eikelboom JW, Rodes-Cabau J. Blood disorders in patients undergoing transcatheter aortic valve replacement: A review. <i>JACC Cardiovasc Interv<\/i> 2019; 12: 1\u201311.","DOI":"10.1016\/j.jcin.2018.09.041"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Blackstone EH, Suri RM, Rajeswaran J, Babaliaros V, Douglas PS, Fearon WF, et al. Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: A placement of aortic transcatheter valves (PARTNER)-I trial substudy. <i>Circulation<\/i> 2015; 131: 1989\u20132000.","DOI":"10.1161\/CIRCULATIONAHA.114.012525"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Arai T, Romano M, Lefevre T, Hovasse T, Farge A, Le Houerou D, et al. Direct comparison of feasibility and safety of transfemoral versus transaortic versus transapical transcatheter aortic valve replacement. <i>JACC Cardiovasc Interv<\/i> 2016; 9: 2320\u20132325.","DOI":"10.1016\/j.jcin.2016.08.009"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kawashima H, Watanabe Y, Kozuma K, Nara Y, Hioki H, Kataoka A, et al. Propensity-matched comparison of percutaneous and surgical cut-down approaches in transfemoral transcatheter aortic valve implantation using a balloon-expandable valve. <i>EuroIntervention<\/i> 2017; 12: 1954\u20131961.","DOI":"10.4244\/EIJ-D-16-00408"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Nakamura M, Chakravarty T, Jilaihawi H, Doctor N, Dohad S, Fontana G, et al. Complete percutaneous approach for arterial access in transfemoral transcatheter aortic valve replacement: A comparison with surgical cut-down and closure. <i>Catheter Cardiovasc Interv<\/i> 2014; 84: 293\u2013300.","DOI":"10.1002\/ccd.25130"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Hernandez-Enriquez M, Andrea R, Brugaletta S, Jimenez-Quevedo P, Hernandez-Garcia JM, Trillo R, et al. Puncture versus surgical cutdown complications of transfemoral aortic valve implantation (from the Spanish TAVI Registry). <i>Am J Cardiol<\/i> 2016; 118: 578\u2013584.","DOI":"10.1016\/j.amjcard.2016.05.054"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Gallet R, Seemann A, Yamamoto M, Hayat D, Mouillet G, Monin JL, et al. Effect of transcatheter (via femoral artery) aortic valve implantation on the platelet count and its consequences. <i>Am J Cardiol<\/i> 2013; 111: 1619\u20131624.","DOI":"10.1016\/j.amjcard.2013.01.332"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Hunt BJ. Bleeding and coagulopathies in critical care. <i>N Engl J Med<\/i> 2014; 370: 847\u2013859.","DOI":"10.1056\/NEJMra1208626"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Watson H, Davidson S, Keeling D, Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: Second edition. <i>Br J Haematol<\/i> 2012; 159: 528\u2013540.","DOI":"10.1111\/bjh.12059"},{"key":"27","unstructured":"27. Warkentin TE, Heddle NM. Laboratory diagnosis of immune heparin-induced thrombocytopenia. <i>Curr Hematol Rep<\/i> 2003; 2: 148\u2013157."}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/84\/6\/84_CJ-19-0875\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T03:25:19Z","timestamp":1590809119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/84\/6\/84_CJ-19-0875\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,25]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-19-0875","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,25]]}}}